TYVASO
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
66302-206 -
Package NDC
66302-206-01 -
Package NDC
66302-206-02 -
Package NDC
66302-206-03 -
Package NDC
66302-206-04 -
Application number
NDA022387 -
SPL ID
78a0b514-481a-4ea9-8ec6-8b60acdf2158 -
SPL set ID
cbc31ab1-a80f-4b50-a3b1-39910b0fb609 -
UNII
RUM6K67ESG -
RxCUI
857795 -
RxCUI
857799
What the source publishes
- Labeler
- United Therapeutics Corporation
- Active ingredients
- treprostinil
- Form
- INHALANT
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "TYVASO",
"splId": "78a0b514-481a-4ea9-8ec6-8b60acdf2158",
"labels": [
{
"setId": "cbc31ab1-a80f-4b50-a3b1-39910b0fb609",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbc31ab1-a80f-4b50-a3b1-39910b0fb609",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cbc31ab1-a80f-4b50-a3b1-39910b0fb609"
}
],
"routes": [
"ORAL"
],
"labeler": "United Therapeutics Corporation",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 BOX in 1 KIT (66302-206-01) / 28 AMPULE in 1 BOX / 2.9 mL in 1 AMPULE",
"package_ndc": "66302-206-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20090814"
},
{
"sample": false,
"description": "1 BOX in 1 KIT (66302-206-02) / 28 AMPULE in 1 BOX / 2.9 mL in 1 AMPULE",
"package_ndc": "66302-206-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20090814"
},
{
"sample": false,
"description": "4 AMPULE in 1 BOX (66302-206-03) / 2.9 mL in 1 AMPULE",
"package_ndc": "66302-206-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20090814"
},
{
"sample": false,
"description": "1 BOX in 1 KIT (66302-206-04) / 4 AMPULE in 1 BOX / 2.9 mL in 1 AMPULE",
"package_ndc": "66302-206-04",
"identifierStatus": "well-formed",
"marketing_start_date": "20090814"
}
],
"productId": "66302-206_78a0b514-481a-4ea9-8ec6-8b60acdf2158",
"useDomain": "unknown",
"dosageForm": "INHALANT",
"productNdc": "66302-206",
"deaSchedule": null,
"genericName": "treprostinil",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TREPROSTINIL",
"strength": "1.74 mg/2.9mL"
}
],
"applicationNumber": "NDA022387",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20090814",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175416",
"M0017817",
"N0000009909"
],
"unii": [
"RUM6K67ESG"
],
"rxcui": [
"857795",
"857799"
],
"spl_set_id": [
"cbc31ab1-a80f-4b50-a3b1-39910b0fb609"
],
"pharm_class_cs": [
"Prostaglandins I [CS]"
],
"pharm_class_pe": [
"Vasodilation [PE]"
],
"pharm_class_epc": [
"Prostacycline Vasodilator [EPC]"
],
"manufacturer_name": [
"United Therapeutics Corporation"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:66302-206_78a0b514-481a-4ea9-8ec6-8b60acdf2158"